Gene · 8324
Papers1,967
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,967
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selective activation of FZD2 and FZD7 reveals non-redundant function during mesoderm differentiation. | Stem Cell Reports | 2025 | 39824186 | PubTator, text mining | PubMed |
| Silencing of FZD7 Inhibits Endometriotic Cell Viability, Migration, and Angiogenesis by Promoting Ferroptosis. | Cell Biochem Biophys | 2025 | 39797998 | PubTator, text mining | PubMed |
| Antibody/siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem-Like Behavior in Triple-Negative Breast Cancer Cells. | J Biomed Mater Res A | 2025 | 39760151 | PubTator, text mining | PubMed |
| Investigating the role of Wnt3a and Wnt5a as critical factors of hepatic stellate cell activation in acute toxicant-induced liver injury. | Cell Biol Toxicol | 2024 | 39707064 | PubTator, text mining | PubMed |
| A Putative Frizzled 7-Targeting Compound Acts as a Firefly Luciferase Inhibitor. | J Med Chem | 2024 | 39670643 | PubTator, text mining | PubMed |
| Conjugation of Antibodies and siRNA Duplexes to Polymer Nanoparticles via Maleimide-Thiol Chemistry. | ACS Omega | 2024 | 39651074 | PubTator, text mining | PubMed |
| Structural and Functional Insights into Dishevelled-Mediated Wnt Signaling. | Cells | 2024 | 39594618 | PubTator, text mining | PubMed |
| Drug resistance biomarkers in ovarian cancer: a bibliometric study from 2017 to 2022. | Front Oncol | 2024 | 39588300 | PubTator, text mining | PubMed |
| SIRT7 stabilizes β-catenin and promotes canonical Wnt activation via upregulating FZD7. | Life Sci | 2024 | 39542206 | PubTator, text mining | PubMed |
| Structural basis of frizzled 7 activation and allosteric regulation. | Nat Commun | 2024 | 39198452 | PubTator, text mining | PubMed |
| Characterization of the tumor microenvironment in breast cancer brain metastasis. | Heliyon | 2024 | 39157383 | PubTator, text mining | PubMed |
| We need to talk-how muscle stem cells communicate. | Front Cell Dev Biol | 2024 | 39050890 | PubTator, text mining | PubMed |
| Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple-Negative Breast Cancer. | Adv Ther (Weinh) | 2024 | 39006318 | PubTator, text mining | PubMed |
| N-glycosylation of Wnt3 regulates the progression of hepatocellular carcinoma by affecting Wnt/β-catenin signal pathway. | World J Gastrointest Oncol | 2024 | 38994173 | PubTator, text mining | PubMed |
| E3 ligases RNF43 and ZNRF3 display differential specificity for endocytosis of Frizzled receptors. | Life Sci Alliance | 2024 | 38969364 | PubTator, text mining | PubMed |
| Correction: Integrin-linked kinase-frizzled 7 interaction maintains cancer stem cells to drive platinum resistance in ovarian cancer. | J Exp Clin Cancer Res | 2024 | 38907260 | PubTator, text mining | PubMed |
| Identification of Potential Ferroptosis Biomarkers and Analysis of Immune Cell Infiltration in Psoriasis Using Machine Learning. | Clin Cosmet Investig Dermatol | 2024 | 38835517 | PubTator, text mining | PubMed |
| Design principles and therapeutic applications of novel synthetic WNT signaling agonists. | iScience | 2024 | 38832011 | PubTator, text mining | PubMed |
| Integrin-linked kinase-frizzled 7 interaction maintains cancer stem cells to drive platinum resistance in ovarian cancer. | J Exp Clin Cancer Res | 2024 | 38822429 | PubTator, text mining | PubMed |
| HAS2 facilitates glioma cell malignancy and suppresses ferroptosis in an FZD7-dependent manner. | Cancer Sci | 2024 | 38816349 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8324/papers?page=4